Spanish Registry of Cardioneuroablation (SRCNA)
Spanish multicenter registry of cardioneuroablation (ablation of cardiac ganglionated plexi) in patients with reflex syncope and functional bradyarrhythmias Background Cardioneuroablation (CNA) is the catheter ablation of the ganglionated plexi (GP) of the intrinsic cardiac autonomic nervous system, located in the atrial epicardial fat, to reduce parasympathetic tone on the sinus node and the atrioventricular (AV) node. It has been proposed as an alternative to pacemaker implantation in patients, often young, with cardioinhibitory reflex syncope or vagally mediated bradyarrhythmias. However, the available evidence comes mainly from single-center series at highly experienced centers, with heterogeneous techniques (choice of atrium, number of GP targeted, localization method, type of anesthesia) and no standardized acute procedural endpoint. Data from real-world clinical practice are needed to define its efficacy and safety, and to identify which patients and which procedural strategies are associated with better outcomes.
Objectives Primary: to assess syncope recurrence after CNA in real-world clinical practice in Spain.
Secondary: 1) to describe the procedural characteristics and complications of CNA; 2) to identify clinical and procedural predictors of success; 3) to evaluate the change in syncope and presyncope burden and the need for pacemaker implantation during follow-up.
Design Observational, multicenter, ambispective, ongoing registry with 27 participating hospitals in Spain. Cases performed since June 2018 are collected retrospectively, and prospective enrollment of consecutive patients has been in place since April 2021.
Study population
Inclusion criteria: consecutive patients undergoing CNA for syncope with one of the following phenotypes:
- Cardioinhibitory reflex syncope: bradycardia <40 bpm or asystole documented on tilt testing, Holter monitoring or implantable loop recorder.
- Mixed reflex syncope: blood pressure drop preceding the heart rate drop on tilt testing.
- Functional sinus node dysfunction.
- Functional AV block. Procedure
CNA is performed according to the usual practice of each center. The operator chooses:
- the approach (right atrium, left atrium or both);
- the number of GP targeted;
- the GP localization method (anatomical, fragmented electrograms, high-frequency stimulation, extracardiac vagal stimulation or combinations);
- the type of anesthesia (general anesthesia, deep sedation, conscious sedation). Data collected
- Baseline: demographics, body mass index, cardiovascular history and structural heart disease, type of syncope, number of syncopal and presyncopal episodes before CNA, and diagnostic tests (tilt testing, Holter, implantable loop recorder, atropine test).
- Procedural: approach, GP targeted, localization method, type of anesthesia, ablation catheter and navigation system, RF power and number of applications, procedure and fluoroscopy times, heart rate before and after CNA and response to atropine after the procedure.
- Safety: procedure-related complications, including sinus node dysfunction, inappropriate sinus tachycardia and vascular complications.
- Follow-up: syncope and presyncope recurrence, number of episodes per year, need for pacemaker implantation and other clinical events.
Endpoints Primary endpoint: first syncope recurrence after CNA. Secondary endpoints: procedure-related complications; number of syncopal and presyncopal episodes per year before and after CNA; pacemaker implantation during follow-up.
Ongoing sub-studies:
- long-term follow-up of these patients and identification of predictors of recurrence;
- redo procedures, in patients requiring more than one CNA;
- patients followed with an implantable loop recorder (subcutaneous Holter). Expected relevance This registry will provide multicenter real-world data on CNA in Spain. It will help to identify the patients most likely to benefit from the procedure and the technical aspects associated with success, and will generate hypotheses for future randomized trials.
Studie Overzicht
Toestand
Toestand
Conditie
Conditie
Interventie / Behandeling
Interventie / Behandeling
Studietype
Studietype
Inschrijving (Geschat)
Inschrijving
Contacten en locaties
Studiecontact
Studiecontact
- Naam: Maria T Barrio-Lopez, MD PhD
- Telefoonnummer: +34 655298270
- E-mail: terebarriol@gmail.com
Studie Contact Back-up
- Naam: Jesus Almendral
- E-mail: almendraljesus@gmail.com
Studie Locaties
-
-
-
Albacete, Spanje
- Werving
- Hospital Albacete
-
Alicante, Spanje
- Werving
- Hospital General Alicante
-
Contact:
- Jose Luis Ibañez
- E-mail: ppluic77@gmail.com
-
Badajoz, Spanje
- Werving
- Hospital Badajoz
-
Barcelona, Spanje
- Werving
- Hospital Dexeus Barcelona
-
Contact:
- Ángel Moya
- E-mail: amoyamitjans@gmail.com
-
Barcelona, Spanje
- Werving
- Hospital Vall d´Hebron
-
Bilbao, Spanje
- Werving
- Hospital de Basurto
-
Contact:
- Jesus Martinez
- E-mail: txules@gmail.com
-
Córdoba, Spanje
- Werving
- Hospital Reina Sofia
-
Girona, Spanje
- Werving
- Hospital Josep Trueta
-
Granada, Spanje
- Werving
- Hospital Virgen de las Nieves
-
Granada, Spanje
- Werving
- Hospital Clinico Granada
-
Contact:
- Rosa Macias
- E-mail: rmacias148@msn.com
-
Huelva, Spanje
- Werving
- Hospital Juan Ramón Jiménez
-
Madrid, Spanje
- Werving
- Hospital Puerta de Hierro
-
Contact:
- Eusebio Garcia Izquierdo
- E-mail: usegij@gmail.com
-
Madrid, Spanje
- Werving
- Hospital 12 de Octubre
-
Contact:
- Alvaro Marco, amarco89@hotmail.com
-
Madrid, Spanje
- Werving
- Hospital Fundación Jiménez Díaz
-
Madrid, Spanje
- Werving
- Hospital Gregorio Marañon
-
Madrid, Spanje
- Werving
- Hospital Ramón y Cajal
-
Contact:
- Eduardo Franco
- E-mail: efranco@academiamir.com
-
Madrid, Spanje
- Werving
- Hospital Torrejon
-
Contact:
- Teba González
- E-mail: tebagf@gmail.com
-
Navarro, Spanje
- Werving
- Hospital Universitario de Navarra
-
Contact:
- Oscar Alcalde
- E-mail: 37053oar@gmail.com
-
Santander, Spanje
- Werving
- Hospital Valdecilla
-
Santiago de Compostela, Spanje
- Werving
- Hospital Santiago de Compostela
-
Contact:
- Carlos Minguito
- E-mail: carlosminguito@hotmail.es
-
Valencia, Spanje
- Werving
- Hospital La Fe
-
Valladolid, Spanje
- Werving
- Hospital Valladolid
-
Vigo, Spanje
- Werving
- Hospital Álvaro Cunqueiro
-
Vitoria-Gasteiz, Spanje
- Werving
- Hospital Txagorritxu
-
Zaragoza, Spanje
- Werving
- Hospital Miguel Servet
-
-
Madrid
-
Madrid, Madrid, Spanje, 28660
- Werving
- Hospital HM Monteprincipe
-
Contact:
- Teresa Barrio, MD PhD
- Telefoonnummer: 655298270
- E-mail: terebarriol@gmail.com
-
Madrid, Madrid, Spanje
- Werving
- Hospital La Paz
-
Contact:
- Carlos Alvarez
- E-mail: calvarezo@gmail.com
-
-
Deelname Criteria
Geschiktheidscriteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Kind
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
patients treated with cardioneuroablation
Beschrijving
Inclusion Criteria:
- patients treated with cardioneuroablation
Exclusion Criteria:
-
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: COHORT
- Tijdsperspectieven: PROSPECTIVE
Wat meet het onderzoek?
Primaire uitkomstmaten
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
syncope
Tijdsspanne: From the procedure (cardioneurobation) to short-term follow up (3 months) and long term follow up (one-year recurrence, 2- year, 3-year and 4-year recurrence)
|
recurrence of syncope |
From the procedure (cardioneurobation) to short-term follow up (3 months) and long term follow up (one-year recurrence, 2- year, 3-year and 4-year recurrence)
|
Secundaire uitkomstmaten
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Complications
Tijdsspanne: During procedure and 3 months after
|
Complications |
During procedure and 3 months after
|
Medewerkers en onderzoekers
Sponsor
Sponsor
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Studie start
Primaire voltooiing (Geschat)
Primaire voltooiing
Studie voltooiing (Geschat)
Studie voltooiing
Studieregistratiedata
Eerst ingediend
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Eerst geplaatst
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update geplaatst
Laatste update ingediend die voldeed aan QC-criteria
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
- Neurologische manifestaties
- Ziekten van het zenuwstelsel
- Neurologische gedragsmanifestaties
- Primaire dysautonomieën
- Ziekten van het autonome zenuwstelsel
- Orthostatische intolerantie
- Bewustzijnsstoornissen
- Bewusteloosheid
- Syncope
- Pathologische aandoeningen, tekenen en symptomen
- Tekenen en symptomen
- Syncope, Vasovagal
Andere studie-ID-nummers
Andere studie-ID-nummers
- SEC2021
- Spanish Society of Cardiology (Ander subsidie-/financieringsnummer: Cardiac Rhythm society)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .